Transdermal Drug Delivery Systems Market Global OutlookPosted by Rahul Gautam on January 10th, 2023 The global transdermal drug delivery systems market size reached US$ 6.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2027, exhibiting a growth rate (CAGR) of 6.36% during 2022-2027. The increasing prevalence of chronic, cardiovascular, and central nervous system disorders and the rising need for self-administration drug delivery systems are majorly driving the transdermal drug delivery systems market growth. Market Outlook: Transdermal drug delivery systems (TDDS) are self-contained dosages that administer biological active agents and cosmeceuticals through the patient’s skin at a predetermined amount. They use appendageal, transcellular, and intercellular as three main routes for drug penetration. TDDS offer painless delivery with prolonged therapeutic effects, improved bioavailability, even plasma levels, and lesser side effects. Consequently, TDDS are utilized as an effective alternative to subcutaneous, oral intravascular, and transmucosal routes for pain management and treatment of various ailments. At present, TDDS mainly include scopolamine, nicotine, nitro-glycerine, and lidocaine as standard drugs. Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours. Request to get the sample report: https://www.imarcgroup.com/transdermal-drug-delivery-systems-market/requestsample Market Trends: The widespread adoption of transdermal patches across the healthcare sector to treat diabetes is supplementing the product demand in the market. Moreover, growing awareness amongst patients regarding various benefits of transdermal patches, such as enhanced convenience and bioavailability with reduced dosing frequency and adverse effects, is favoring the market growth. Additionally, the advent of mHealth and homecare settings and the shifting preference toward transdermal drug delivery, due to their heightened drug diffusion capabilities and pain-free medication administration, are creating a positive outlook for the market. Besides this, the large-scale integration of microneedles or mechanical arrays, pressure-sensitive adhesives, and permeation enhancers in transdermal patches and ongoing research and development (R&D) activities are positively stimulating the market growth. Transdermal Drug Delivery Systems Market 2022-2027 Competitive Analysis and Segmentation: Competitive Landscape with Key Players: The competitive landscape of the global transdermal drug delivery systems market has been studied in the report with the detailed profiles of the key players operating in the market. List of Key Companies Covered in this Market Report:
Market Segmentation: The report has segmented the global transdermal drug delivery systems market on the basis of technology, application and region. Based on Technology:
Based on Application:
Geographical Analysis:
Make inquiry before purchase of this report: https://www.imarcgroup.com/request?type=report&id=3983&flag=F Key Highlights of the Report:
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization. About Us IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. Contact Us: Like it? Share it! More by this author |